VeriSIM Life

Szczepan Baran

Dr. Szczepan Baran currently serves as a Chief Scientific Officer at VeriSIM Life where he leads the research and development strategy and oversees scientific functions and products. He previously served as a Head of Emerging Technologies within Comparative Medicine at Novartis. In this position, he led an integrated digital enterprise strategy focusing on developing and incorporating patient-relevant AI technologies and conducted decentralized clinical trials (DCT).


Szczepan has held multiple start-up and faculty positions and served on numerous boards. He chaired the IQ MPS Affiliate and led the IQ MPS Affiliate Regulatory Outreach Group. Currently, he serves as an advisory board member at BRIDGE, ad hoc member of National Academies on the NHP Model Systems Committee, a co-chair of the MPS and Translational Digital Biomarker Initiatives of the North American 3Rs Collaborative, and serves on the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) ad hoc member.


Szczepan is a graduate of the University of Delaware and the University of Pennsylvania School of Veterinary Medicine. He completed his residency in Laboratory Animal Medicine and received a Master of Science degree in Comparative Medicine from the University of Washington.